ZA952644B - Immunotherapeutic agent and its use - Google Patents

Immunotherapeutic agent and its use

Info

Publication number
ZA952644B
ZA952644B ZA952644A ZA952644A ZA952644B ZA 952644 B ZA952644 B ZA 952644B ZA 952644 A ZA952644 A ZA 952644A ZA 952644 A ZA952644 A ZA 952644A ZA 952644 B ZA952644 B ZA 952644B
Authority
ZA
South Africa
Prior art keywords
immunotherapeutic agent
immunotherapeutic
agent
Prior art date
Application number
ZA952644A
Other languages
English (en)
Inventor
Graham Arthur William Rook
John Lawson Stanford
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of ZA952644B publication Critical patent/ZA952644B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA952644A 1994-03-30 1995-03-30 Immunotherapeutic agent and its use ZA952644B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9406301A GB9406301D0 (en) 1994-03-30 1994-03-30 Immunotherapeutic agent and its use

Publications (1)

Publication Number Publication Date
ZA952644B true ZA952644B (en) 1996-01-11

Family

ID=10752750

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952644A ZA952644B (en) 1994-03-30 1995-03-30 Immunotherapeutic agent and its use

Country Status (22)

Country Link
EP (1) EP0752870B1 (fr)
JP (1) JP4135190B2 (fr)
KR (1) KR100392582B1 (fr)
CN (1) CN1121874C (fr)
AP (1) AP9600861A0 (fr)
AT (1) ATE218355T1 (fr)
AU (1) AU699081B2 (fr)
BR (1) BR9507338A (fr)
CA (1) CA2186851C (fr)
CZ (1) CZ280196A3 (fr)
DE (1) DE69526935T2 (fr)
DK (1) DK0752870T3 (fr)
ES (1) ES2177638T3 (fr)
FI (1) FI111223B (fr)
GB (1) GB9406301D0 (fr)
HU (1) HU220858B1 (fr)
NO (1) NO964075L (fr)
NZ (1) NZ282863A (fr)
PT (1) PT752870E (fr)
RU (1) RU2139728C1 (fr)
WO (1) WO1995026742A1 (fr)
ZA (1) ZA952644B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
EP0951289B1 (fr) * 1996-12-18 2005-10-26 Stanford Rook Limited Utilisation de mycobacterium vaccae pour le traitement du syndrome de fatigue chronique
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
WO2003063896A1 (fr) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Procede de preparation d'une composition pharmaceutique pour conferer l'immunite contre la tuberculose a des individus hiv-positifs
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
CN101022826A (zh) * 2004-06-07 2007-08-22 哈罗尔·戴维·贡 用于癌症治疗的细菌组合物
BG66067B1 (bg) * 2005-05-18 2011-01-31 Спартак ХАДЖИЕВ Средство с антитуморна активност на база бцж ваксина, метод за неговото получаване и използването му
US8557257B2 (en) 2006-03-24 2013-10-15 Oncovac Inc. Mycobacterial immunotherapy for cancer treatment
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
PL2598165T3 (pl) 2010-07-26 2018-02-28 Qu Biologics Inc. Immunogenne kompozycje przeciwzapalne
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
WO2016207646A1 (fr) * 2015-06-24 2016-12-29 Immodulon Therapeutics Limited Inhibiteur de point de vérification et mycobactérie à germes entiers destinés à une utilisation dans le traitement de cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions

Also Published As

Publication number Publication date
ES2177638T3 (es) 2002-12-16
PT752870E (pt) 2002-09-30
BR9507338A (pt) 1997-09-16
NO964075D0 (no) 1996-09-27
AU2078595A (en) 1995-10-23
CN1150388A (zh) 1997-05-21
CN1121874C (zh) 2003-09-24
AP9600861A0 (en) 1996-10-31
FI111223B (fi) 2003-06-30
MX9604401A (es) 1997-12-31
FI963866L (fi) 1996-09-27
EP0752870A1 (fr) 1997-01-15
RU2139728C1 (ru) 1999-10-20
DK0752870T3 (da) 2002-07-15
NZ282863A (en) 2001-06-29
HU220858B1 (en) 2002-06-29
DE69526935T2 (de) 2002-09-19
CZ280196A3 (en) 1997-02-12
NO964075L (no) 1996-11-25
KR970702057A (ko) 1997-05-13
KR100392582B1 (ko) 2003-10-30
ATE218355T1 (de) 2002-06-15
GB9406301D0 (en) 1994-05-25
JPH09511737A (ja) 1997-11-25
CA2186851C (fr) 2008-11-18
CA2186851A1 (fr) 1995-10-12
FI963866A0 (fi) 1996-09-27
EP0752870B1 (fr) 2002-06-05
HUT75835A (en) 1997-05-28
JP4135190B2 (ja) 2008-08-20
WO1995026742A1 (fr) 1995-10-12
AU699081B2 (en) 1998-11-19
HU9602661D0 (en) 1996-11-28
DE69526935D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
IL115891A0 (en) Hemorrhoidial compositions and their use
ZA9711141B (en) Novel ketobenzamides and their use
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
EP0776339A4 (fr) Complexes bases sur le complexe majeur d'histocompabilite et leurs applications
HUT75835A (en) Immunotherapeutic agent and its use
GB9525812D0 (en) Composition and use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
GB9411045D0 (en) Compounds and use
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
GB9423267D0 (en) Compounding elements and use thereof
GB9525048D0 (en) Composition compound and use
GB9412618D0 (en) Cytotoxic agent and its use
GB9413076D0 (en) Composition and use
GB9501907D0 (en) Allatostatins and their use
IL115853A0 (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas
GB9412689D0 (en) Cytotoxic agent and its use
GB9403333D0 (en) Compound and use
GB9420243D0 (en) Complex and its use
GB9525024D0 (en) Composition compound and use
GB9426435D0 (en) Compound and its use
GB9512703D0 (en) Composition and use
GB9411634D0 (en) Use and compounds
GB9417562D0 (en) Compounds and their use
GB9414881D0 (en) Compounds and their use
GB9409825D0 (en) New use and compositions